Search results
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Zacks via Yahoo Finance· 1 hour agoAZN boasts a Momentum Style Score of B and VGM Score of B, and holds a Zacks Rank #3 (Hold) rating....
Pharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails
Zacks via Yahoo Finance· 2 hours ago(See the last pharma stock roundup here:Pharma Stock Roundup: LLY’s CFO Departs, ABBV, AZN Drugs Get...
Why AstraZeneca plc (NASDAQ:AZN) is Investors’ One of Favorite International Dividend Stock?
Insider Monkey via Yahoo Finance· 3 days agoWe recently compiled a list of 12 Best International Dividend Stocks to Buy Now. Since AstraZeneca...
AstraZeneca PLC (OTCMKTS:AZNCF) Sees Large Drop in Short Interest
ETF DAILY NEWS· 1 day agoAstraZeneca PLC (OTCMKTS:AZNCF – Get Free Report) was the recipient of a significant decline in short interest in May. As of May 31st, there was short interest totalling 21,000 ...
FDA Expands AstraZeneca's (AZN) Farxiga Label in Pediatric T2D
Zacks via Yahoo Finance· 1 day agoFollowing the label expansion, AstraZeneca's (AZN) Farxiga is now approved to improve glycemic...
AstraZeneca CFO: 'We've come a long way in our oncology portfolio'
Yahoo Finance via AOL· 24 hours agoAstraZeneca has set a target to become an $80 billion company, in sales, by 2030. In 2023, the...
Meet The International Megacaps That 'Match Or Surpass' Magnificent Seven Stocks
Investor's Business Daily· 4 days agoNovo Nordisk stock also earns a spot on the IBD 50 list of top growth stocks, as well as IBD...
Insmed retains rights to brensocatib after talks with AstraZeneca end By Investing.com
Investing.com· 1 day agoInsmed (NASDAQ:INSM) Incorporated, a pharmaceutical company based in Bridgewater, New Jersey,...
Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks
Investor's Business Daily· 1 day agoThe company had two earlier flops in COPD treatment, but is now running a Phase 3 study of more than...
AstraZeneca PLC (NASDAQ:AZN) Receives Consensus Recommendation of “Moderate Buy” from Analysts
ETF DAILY NEWS· 5 days agoAstraZeneca PLC (NASDAQ:AZN – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the nine ratings firms that are currently covering the company, ...